David A. Ramsay, CFO of Halozyme Therapeutics HALO, has filed 7 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $121.2K. The latest trade was on 04/01.

DR

DR

David A. Ramsay

Interim CFO

Company

Halozyme Therapeutics HALO

First filing

23/01/03

Trades

12 trades

Buys / sales

7 / 1

12-month net buying

−$121.2K

Last trade

04/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
SavaraSVRA	Open-market sale	25/12/19	25/12/19	20,000 sh	$6.06	$121,200	−0.8%
SavaraSVRA	Open-market buy	25/03/31	25/04/01	150,000 sh	$2.78	$417,000	+6.3%
SavaraSVRA	Open-market buy	24/11/18	24/11/18	100,000 sh	$2.88	$288,000	+4.5%
SavaraSVRA	Open-market buy	23/05/24–23/05/26	23/05/26	100,000 sh3 trades	$2.59avg.	$258,727.44	+4.8%
SavaraSVRA	Open-market buy	22/12/29–22/12/30	23/01/03	36,000 sh2 trades	$1.55avg.	$55,730	+1.7%